Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Alzamend Neuro, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −11 vs. Q3 2023
- Shares held
- 374.4K
- −46.0K (−10.9%) vs. Q3 2023Converted for a 1-for-15 split
- Total value
- $334.7K
- −$1.16M (−77.6%) vs. Q3 2023
- New holders
- 4
- 5 more added
- Sold out
- 15
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $3.26M |
| Q1 2026 | 13 | $723.1K |
| Q4 2025 | 13 | $447.2K |
| Q3 2025 | 11 | $351.3K |
| Q2 2025 | 7 | $6.36K |
| Q1 2025 | 11 | $59.9K |
| Q4 2024 | 17 | $131.7K |
| Q3 2024 | 12 | $71.2K |
| Q2 2024 | 16 | $150.5K |
| Q1 2024 | 13 | $386.8K |
| Q4 2023 | 16 | $334.7K |
| Q3 2023 | 27 | $1.49M |
| Q2 2023 | 24 | $3.13M |
| Q1 2023 | 26 | $2.64M |
| Q4 2022 | 33 | $3.98M |
| Q3 2022 | 17 | $9.41M |
| Q2 2022 | 21 | $2.70M |
| Q1 2022 | 22 | $4.01M |
| Q4 2021 | 20 | $1.66M |
| Q3 2021 | 17 | $1.99M |
| Q2 2021 | 11 | $2.58M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Alzamend Neuro, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Truist Financial Corp | 154,327 | $137.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Vanguard Group Inc | 78,545 | $69.9K | 0.00% | −57,139−42.1% | ReducedConverted for a 1-for-15 split |
| Geode Capital Management, LLC | 52,397 | $48.2K | 0.00% | +9,996+23.6% | AddedConverted for a 1-for-15 split |
| BlackRock Inc. | 39,740 | $35.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| HRT Financial LP | 16,806 | $15.0K | 0.00% | +16,806 | New |
| RFG Advisory, LLC | 16,666 | $14.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Renaissance Technologies LLC | 10,190 | $9.00K | 0.00% | +8,763+614.3% | AddedConverted for a 1-for-15 split |
| Tower Research Capital LLC (TRC) | 3,316 | $2.95K | 0.00% | +76+2.3% | AddedConverted for a 1-for-15 split |
| UBS Group AG | 1,909 | $1.70K | 0.00% | +1,381+261.2% | AddedConverted for a 1-for-15 split |
| Harbor Investment Advisory, LLC | 200 | $178 | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Advisor Group Holdings, Inc. | 66 | $59 | 0.00% | −1−1.0% | ReducedConverted for a 1-for-15 split |
| Baystate Wealth Management LLC | 66 | $59 | 0.00% | +66 | New |
| Bank of America Corp | 47 | $42 | 0.00% | +47 | New |
| Wells Fargo & Company | 35 | $31 | 0.00% | +2+6.1% | AddedConverted for a 1-for-15 split |
| Morgan Stanley | 33 | $29 | 0.00% | −0−1.0% | ReducedConverted for a 1-for-15 split |
| Parallel Advisors, LLC | 33 | $29 | 0.00% | +33 | New |
| Northern Trust Corp | 0 | $0 | 0.00% | −6,918−100.0% | Sold outConverted for a 1-for-15 split |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −3,539−100.0% | Sold outConverted for a 1-for-15 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −2,691−100.0% | Sold outConverted for a 1-for-15 split |
| Integrated Investment Consultants, LLC | 0 | $0 | 0.00% | −2,667−100.0% | Sold outConverted for a 1-for-15 split |
| State Street Corp | 0 | $0 | 0.00% | −2,127−100.0% | Sold outConverted for a 1-for-15 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,877−100.0% | Sold outConverted for a 1-for-15 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,842−100.0% | Sold outConverted for a 1-for-15 split |
| Foundations Investment Advisors, LLC | 0 | $0 | 0.00% | −1,333−100.0% | Sold outConverted for a 1-for-15 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −1,111−100.0% | Sold outConverted for a 1-for-15 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −865−100.0% | Sold outConverted for a 1-for-15 split |
| Insight Wealth Strategies, LLC | 0 | $0 | 0.00% | −667−100.0% | Sold outConverted for a 1-for-15 split |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −333−100.0% | Sold outConverted for a 1-for-15 split |
| FMR LLC | 0 | $0 | 0.00% | −18−100.0% | Sold outConverted for a 1-for-15 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3−100.0% | Sold outConverted for a 1-for-15 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold outConverted for a 1-for-15 split |